Hepatitis B vaccine after newborn surgery
Part of Blood & lymphatic, Digestive system, Immune system & allergy, Infections clinical trials.
This trial tests whether giving the hepatitis B vaccine to full-term newborns who had multiple stomach or intestine surgeries is safe and works well. It aims to protect these babies from hepatitis B infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born full-term (not premature).
- Your baby had multiple surgeries on their stomach or intestines.
- Your baby does not have hepatitis B (tested negative).
- Your baby has no problems with their immune system.
- Your baby does not have serious issues with their heart, brain, liver, kidneys, or other major organs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body's immune system responds in people with chronic hepatitis B who also need surgery on certain organs. The goal is to learn more about the immune reaction in tonsils, lymph nodes, or other tissues to help find better treatments for hepatitis B.
This trial looks at the best time to give the hepatitis B vaccine to people who have had a stem cell transplant and are in remission. It may help find the safest and most effective timing for vaccination.
This study compares two ways of treating hepatitis B in pregnant women to prevent passing the virus to their babies. It tests whether a standard universal treatment approach works better than a quick, point-of-care test-based strategy.
This trial tests antiviral therapy in babies under 1 year old who have hepatitis B virus (HBV) but no other liver infections. The goal is to see if treatment can help control the virus and protect their liver.
This trial tests an experimental vaccine therapy to help control or possibly cure chronic hepatitis B. It is designed to see whether the treatment is safe and how well it affects the hepatitis B virus in adults.
This early-phase study tests whether a hepatitis B vaccine (with an added ingredient to boost the immune response) can safely help people with long-term hepatitis B who are already on antiviral therapy. It is mainly looking at safety and how the immune system responds.
Hear when a new Vaccination Reaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.